Home
Nath Bio-genes (india) Ltd Quarterly Result

Nath Bio-Genes (India) Ltd
NSE: NATHBIOGEN
Net Profit - Last Quarter
Nath Bio-Genes (India) Ltd Quarterly Results Key Highlights
- The revenue of Nath Bio-Genes (India) Ltd for the Dec '24 is ₹ 37.35 crore as compare to the Sep '24 revenue of ₹ 32.27 crore.
- This represent the growth of 15.74%a1# The ebitda of Nath Bio-Genes (India) Ltd for the Dec '24 is ₹ 8.51 crore as compare to the Sep '24 ebitda of ₹ 4.89 crore.
- This represent the growth of 74.03%a1# The net profit of Nath Bio-Genes (India) Ltd for the Dec '24 is ₹ 2.65 crore as compare to the Sep '24 net profit of ₹ 1.11 crore.
- This represent the growth of 138.74%a1#.
Nath Bio-Genes (India) Ltd Quarterly Results Analysis
Market Price of Nath Bio-Genes (India) Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Apr 2025 | 168.5 |
17 Apr 2025 | 168.1 |
16 Apr 2025 | 162.3 |
15 Apr 2025 | 155.55 |
11 Apr 2025 | 152 |
09 Apr 2025 | 149.3 |
08 Apr 2025 | 150.15 |
07 Apr 2025 | 148.15 |
04 Apr 2025 | 157 |
03 Apr 2025 | 162 |
Historical Revenue of Nath Bio-Genes (India) Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
Historical Revenue of Nath Bio-Genes (India) Ltd
Historical EBITDA of Nath Bio-Genes (India) Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Nath Bio-Genes (India) Ltd
Historical Net Profit of Nath Bio-Genes (India) Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Nath Bio-Genes (India) Ltd
Nath Bio-Genes (India) Ltd News Hub
Nath Bio-Genes (India) consolidated net profit declines 0.24% in the June 2024 quarter
Net profit of Nath Bio-Genes (India) declined 0.24% to Rs 33.35 crore in the quarter ended June 2024
Read more
07 Aug 24
Nath Bio-Genes (India) announces board meeting date
Nath Bio-Genes (India) will hold a meeting of the Board of Directors of the Company on 23 October 20
Read more
17 Oct 24
Nath Bio-Genes (India) standalone net profit rises 79.50% in the September 2024 quarter
Net profit of Nath Bio-Genes (India) rose 79.50% to Rs 2.89 crore in the quarter ended September 202
Read more
23 Oct 24
Nath Bio-Genes (India) consolidated net profit declines 26.49% in the September 2024 quarter
Net profit of Nath Bio-Genes (India) declined 26.49% to Rs 1.11 crore in the quarter ended September
Read more
23 Oct 24